Company intelligence / Profile preview

Shepherd Therapeutics

Natick, Massachusetts, United Statesshepherd.bio ↗

Ownership: Private
Employees: ~16
Development stage: Preclinical

Overview

Shepherd Therapeutics uses a proprietary AI-driven platform to identify, develop, or partner on innovative therapies for rare cancers. As of the last available reports, it had several programs in preclinical or early clinical development but no approved products. The company leverages relationships with disease foundations and academic labs to source high-potential translational science targeting underserved cancer populations.

Therapeutic areas: Oncology
Modalities: Small molecules (e.g., pyrvinium pamoate)Monoclonal antibodies
Industry: Biotech

Drug pipeline

6 assets

SHEP-002

Preclinical

5 more assets in the full pipeline.

Request access →

Partnerships

ACC Research Foundation (collaboration/engagement)Harvard Venture Incubation Program (investor/incubator)Other biopharma companies seeking expansion into rare/orphan indications via partnership/licensing structures

Beyond the preview

Go deeper on Shepherd Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shepherd Therapeutics.

Explore the full profile